The HAN-GINS Indxx Healthcare Megatrend ETF (LON:WELL) co-creator Anthony Ginsberg tells Proactive out of its seven sub-themes, gene editing is the fund's best performer year-to-date. Ginsberg says gene editing is increasingly becoming mainstream following the success of coronavirus vaccines, specifically CRISPR gene editing which will lead to more precision and customizable medicine over time.
The HAN-GINS Indxx Healthcare Megatrend ETF co-creator explains why gene editing is best performer
